ijms-logo

Journal Browser

Journal Browser

Carbohydrate Structures in Targeted Drug Delivery

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".

Deadline for manuscript submissions: 15 June 2024 | Viewed by 1875

Special Issue Editor


E-Mail Website
Guest Editor
University Centre Varaždin, University North, 42 000 Varaždin, Croatia
Interests: organic synthesis; medicinal chemistry; glycoconjugates; glicopeptides; ligand-receptor interactions

Special Issue Information

Dear Colleagues,

The development of safe and highly specific systems for targeted drug delivery is extremely important for improvements in drug therapy effectiveness. Different specialized drug carriers and delivery systems for active and passive drug targeting can be used, such as antibody–drug conjugates, liposomes, nanopolymers, and nanoparticles. Great efforts are being made to improve the selectivity of the targeted drug delivery, a complex process in which properties of the drug, drug carrier, and targeting site should be harmonized. Carbohydrates are natural molecules and have versatile roles in many biological events such as cellular communication, enzyme activities, infections, cancer metastases, and immune functions. Prominent advantages of carbohydrates are biodegradability, biocompatibility, hydrophilicity, and highly specific interaction with target receptors on the cell surface. Due to the above-mentioned characteristics, they are used for the preparation of systems for the targeted delivery of drugs, as well as for the sustained release of drugs, immune antigens, and adjuvants. Therefore, research on the role of carbohydrate structures in targeted drug delivery is needed to overcome drug delivery challenges and improve therapeutic outcomes.

Dr. Rosana Ribić
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • carbohydrates
  • targeted drug delivery
  • drug–target interactions
  • glycoconjugates
  • glyconanoparticles
  • lipid-based drug delivery systems

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 9695 KiB  
Review
Mannose Ligands for Mannose Receptor Targeting
by Marija Paurević, Martina Šrajer Gajdošik and Rosana Ribić
Int. J. Mol. Sci. 2024, 25(3), 1370; https://doi.org/10.3390/ijms25031370 - 23 Jan 2024
Viewed by 1620
Abstract
The mannose receptor (MR, CD 206) is an endocytic receptor primarily expressed by macrophages and dendritic cells, which plays a critical role in both endocytosis and antigen processing and presentation. MR carbohydrate recognition domains (CRDs) exhibit a high binding affinity for branched and [...] Read more.
The mannose receptor (MR, CD 206) is an endocytic receptor primarily expressed by macrophages and dendritic cells, which plays a critical role in both endocytosis and antigen processing and presentation. MR carbohydrate recognition domains (CRDs) exhibit a high binding affinity for branched and linear oligosaccharides. Furthermore, multivalent mannose presentation on the various templates like peptides, proteins, polymers, micelles, and dendrimers was proven to be a valuable approach for the selective and efficient delivery of various therapeutically active agents to MR. This review provides a detailed account of the most relevant and recent aspects of the synthesis and application of mannosylated bioactive formulations for MR-mediated delivery in treatments of cancer and other infectious diseases. It further highlights recent findings related to the necessary structural features of the mannose-containing ligands for successful binding to the MR. Full article
(This article belongs to the Special Issue Carbohydrate Structures in Targeted Drug Delivery)
Show Figures

Figure 1

Back to TopTop